prolaio eVO2peak Module vs DeepRhythmAI
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if your primary objective is to longitudinally assess and monitor a patient's cardiovascular fitness and functional capacity using real-world activity data. This tool is ideal for clinicians and researchers focused on understanding changes in peak oxygen consumption over time, leveraging data from qualified third-party wearable sensors to inform cardiovascular care and rehabilitation strategies.
View prolaio eVO2peak Module →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your priority is rapid, highly accurate, and efficient detection and classification of cardiac arrhythmias from ECG data. This solution is best suited for healthcare providers aiming to significantly streamline their ECG reporting workflows, reduce the incidence of missed arrhythmia diagnoses, and enhance diagnostic precision across a large volume of patient ECGs.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | DeepRhythmAI |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor for pricing information |
| Deployment | Cloud-based (software-only, processes remote sensor data) | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
prolaio eVO2peak ModuleTool A, Prolaio eVO2peak Module, offers a patient-facing mobile app that guides users through monitoring and provides feedback, suggesting a more direct and user-friendly experience for data collection. In contrast, DeepRhythmAI explicitly states it does not include a native user interface and relies on integration with external visualization software, which could lead to variable usability depending on the integrating partner's implementation.
Clinical Value
DeepRhythmAIWhile both tools offer significant clinical value in their respective domains, DeepRhythmAI provides highly compelling, quantifiable claims of reducing missed cardiac arrhythmia diagnoses by 14x to 114x compared to current standards. This direct impact on diagnostic accuracy and patient safety gives it an edge over Prolaio's eVO2peak Module, which serves as an adjunctive aid for estimating peak oxygen consumption.
Pricing & Value
TieNeither Prolaio eVO2peak Module nor DeepRhythmAI provides transparent pricing information in the provided data or through web searches. Both require direct contact for pricing details ('contact for pricing' for Tool A and 'enterprise' for Tool B), making it impossible to compare their value propositions based on cost.
Enterprise Readiness
DeepRhythmAIDeepRhythmAI demonstrates superior enterprise readiness, explicitly targeting a wide range of healthcare systems from solo practices to large health systems and boasting numerous global customers. It also offers an API for integration, supports various deployment models (SaaS, on-prem, hybrid), and adheres to a broader set of compliance and data standards including GDPR, HITECH, SOC 2, ISO 27001, FHIR, HL7 v2, DICOM, SNOMED, and ICD-10.
Innovation
DeepRhythmAIBoth tools leverage advanced AI, but DeepRhythmAI showcases a higher degree of innovation in its core AI methodology by explicitly mentioning the use of cutting-edge CNN and Transformer models. Furthermore, its algorithms are trained on an exceptionally vast dataset of over 250 billion annotated heartbeats, indicating a more robust and sophisticated AI development approach.
Support & Docs
prolaio eVO2peak ModuleProlaio eVO2peak Module explicitly mentions 'Always-on support' and provides a direct contact email for assistance, along with a mobile app that guides patients through the monitoring process. While DeepRhythmAI implies documentation for integrators, it does not detail direct user support or patient guidance, making Prolaio's support structure appear more explicit and accessible for its end-users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | DeepRhythmAI |
|---|---|---|
| Primary Function | Estimates peak oxygen consumption using real-world patient data for cardiovascular research and care. | Revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. |
| Company | Prolaio | Medicalgorithmics S.A. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology |
| Key Specific Functionality | Estimates peak oxygen consumption (eVO2peak) | AI-powered arrhythmia detection and classification |
| Input Data Sources | Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors | ECG data (device-agnostic) |
| AI Model Type | Locked deep-learning model | CNN and Transformer models |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and DeepRhythmAI.